The following Xenical posters were presented at the European Congress on Obesity, 29 May to 1 June 2003.

Posters

Efficacy of orlistat in overweight and obese patients with Metabolic Syndrome
Prevalence of Metabolic Syndrome in overweight and obese patients with cardiovascular risk factors
Patient satisfaction in the Xenical® Weight Management Programmes
Prevalence of Metabolic Syndrome in a cohort of Swedish obese patients
Safety and tolerability of orlistat over 4 years: results of XENDOS – a landmark study

To request an interview or more information please contact us.

To view PDF files, you will need the Adobe Acrobat Reader. Use the icon below to download the Reader.